Clinical Trials Logo

Clostridium Infections clinical trials

View clinical trials related to Clostridium Infections.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT02437500 Approved for marketing - Clinical trials for Clostridioides Difficile Infection

Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)

Start date: n/a
Phase:
Study type: Expanded Access

Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days. The purpose of this study is to provide access to SER-109 for adult subjects with recurrent Clostridioides Difficile Infection (RCDI) and to monitor subject safety and report to regulatory authorities, as appropriate.